Danielle Davis
Family · Bedford, TXNPI 1750959714
Payments from drug & device makers
Across 100 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$263
- Pfizer$231
- Boehringer Ingelheim$143
- Lilly USA, LLC$125
- Bayer$106
- AbbVie$102
- plus $896 from 24 others
What the payments were for
- Food & beverage$1,867100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $263 |
| Pfizer | 12 | $231 |
| Boehringer Ingelheim | 6 | $143 |
| Lilly USA, LLC | 8 | $125 |
| Bayer | 6 | $106 |
| AbbVie | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $86 |
| Shield Therapeutics Inc | 1 | $76 |
| GSK | 4 | $75 |
| AstraZeneca | 4 | $63 |
| Exact Sciences | 3 | $60 |
| Dexcom, Inc. | 3 | $46 |
| Novartis | 3 | $46 |
| Idorsia Pharmaceuticals US Inc | 2 | $46 |
| Nestle Healthcare Nutrition Inc. | 2 | $34 |
| Antares Pharma, Inc. | 2 | $33 |
| Eisai Inc. | 1 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Biogen | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Evoke Pharma, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Avvisto Therapeutics, LLC | 1 | $15 |
| Halozyme Inc | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$1,867 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 43 | $68,158 |
| JardianceEmpagliflozin | 12 | $15,669 |
| TrulicityDulaglutide | 14 | $14,246 |
| MyrbetriqMirabegron | 21 | $10,961 |
| EliquisApixaban | 13 | $9,145 |
| Aripiprazole | 11 | $2,860 |
| EdarbiAzilsartan Medoxomil | 18 | $2,101 |
| Duloxetine Hcl | 29 | $1,515 |
| Levothyroxine Sodium | 142 | $1,380 |
| Gabapentin | 76 | $1,150 |
| Potassium Chloride | 50 | $1,145 |
| Atorvastatin Calcium | 70 | $1,130 |
| Donepezil Hcl | 35 | $1,035 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,022 |
| Famotidine | 11 | $885 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $20 | $68,15843 claims |
| Boehringer IngelheimJardiance | $143 | $15,66912 claims |
| Lilly USA, LLCTrulicity | $125 | $14,24614 claims |
| Astellas Pharma US IncMyrbetriq | $13 | $10,96121 claims |
| PfizerEliquis | $231 | $9,14513 claims |
| Arbor Pharmaceuticals, Inc.Edarbi | $17 | $2,10118 claims |
| AbbVieSynthroid | $102 | $43716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 15,456 family providers in Texas.
Other family in Bedford
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.